Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1984 1
1985 1
1986 3
1987 4
1988 4
1989 2
1990 3
1991 2
1992 1
1993 2
1994 2
1995 1
1996 1
1998 4
1999 3
2000 1
2001 4
2002 3
2003 3
2004 1
2005 5
2006 4
2007 2
2008 5
2009 1
2010 2
2011 6
2012 5
2013 4
2014 2
2015 5
2016 2
2017 5
2018 5
2019 7
2020 5
2021 8
2022 12
2023 9
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean k imamura[Author] (416 results)?
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Duncavage EJ, Bagg A, Hasserjian RP, DiNardo CD, Godley LA, Iacobucci I, Jaiswal S, Malcovati L, Vannucchi AM, Patel KP, Arber DA, Arcila ME, Bejar R, Berliner N, Borowitz MJ, Branford S, Brown AL, Cargo CA, Döhner H, Falini B, Garcia-Manero G, Haferlach T, Hellström-Lindberg E, Kim AS, Klco JM, Komrokji R, Lee-Cheun Loh M, Loghavi S, Mullighan CG, Ogawa S, Orazi A, Papaemmanuil E, Reiter A, Ross DM, Savona M, Shimamura A, Skoda RC, Solé F, Stone RM, Tefferi A, Walter MJ, Wu D, Ebert BL, Cazzola M. Duncavage EJ, et al. Among authors: shimamura a. Blood. 2022 Nov 24;140(21):2228-2247. doi: 10.1182/blood.2022015853. Blood. 2022. PMID: 36130297 Free PMC article.
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.
Li M, Nishimura T, Takeuchi Y, Hongu T, Wang Y, Shiokawa D, Wang K, Hirose H, Sasahara A, Yano M, Ishikawa S, Inokuchi M, Ota T, Tanabe M, Tada KI, Akiyama T, Cheng X, Liu CC, Yamashita T, Sugano S, Uchida Y, Chiba T, Asahara H, Nakagawa M, Sato S, Miyagi Y, Shimamura T, Nagai LAE, Kanai A, Katoh M, Nomura S, Nakato R, Suzuki Y, Tojo A, Voon DC, Ogawa S, Okamoto K, Foukakis T, Gotoh N. Li M, et al. Among authors: shimamura t. J Clin Invest. 2023 Nov 15;133(22):e166666. doi: 10.1172/JCI166666. J Clin Invest. 2023. PMID: 37966117 Free PMC article.
Importantly, FXYD3+ CSCs were sensitive to senolytic Na+/K+ pump inhibitors, such as cardiac glycosides. Together, our data indicate that FXYD3+ CSCs with ancestral features are drivers of plasticity and chemoresistance in TNBC. Targeting the Na+/K+ pump could be an …
Importantly, FXYD3+ CSCs were sensitive to senolytic Na+/K+ pump inhibitors, such as cardiac glycosides. Together, our data indicate …
The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.
Makaryan V, Zeidler C, Bolyard AA, Skokowa J, Rodger E, Kelley ML, Boxer LA, Bonilla MA, Newburger PE, Shimamura A, Zhu B, Rosenberg PS, Link DC, Welte K, Dale DC. Makaryan V, et al. Among authors: shimamura a. Curr Opin Hematol. 2015 Jan;22(1):3-11. doi: 10.1097/MOH.0000000000000105. Curr Opin Hematol. 2015. PMID: 25427142 Free PMC article. Review.
Preclinical study of a DNA vaccine targeting SARS-CoV-2.
Hayashi H, Sun J, Yanagida Y, Otera T, Kubota-Koketsu R, Shioda T, Ono C, Matsuura Y, Arase H, Yoshida S, Nakamaru R, Ju N, Ide R, Tenma A, Kawabata S, Ehara T, Sakaguchi M, Tomioka H, Shimamura M, Okamoto S, Amaishi Y, Chono H, Mineno J, Komatsuno T, Saito Y, Rakugi H, Morishita R, Nakagami H. Hayashi H, et al. Among authors: shimamura m. Curr Res Transl Med. 2022 Sep;70(4):103348. doi: 10.1016/j.retram.2022.103348. Epub 2022 Apr 20. Curr Res Transl Med. 2022. PMID: 35489099 Free PMC article.
High Piezoelectric Performance in Undoped (K,Na)NbO(3) Piezoceramics over a Wide Range of Compositions.
Vaschalde L, Víllora EG, Shimamura K. Vaschalde L, et al. Among authors: shimamura k. Inorg Chem. 2023 Nov 13;62(45):18485-18495. doi: 10.1021/acs.inorgchem.3c02680. Epub 2023 Nov 1. Inorg Chem. 2023. PMID: 37910846
In a previous study, an optimized low-temperature (LT) sintering process for the preparation of high-performance undoped (K,Na)NbO(3) (KNN) ceramics with high density, high reproducibility, and high chemical stability was established for the K = 50% composition. ... …
In a previous study, an optimized low-temperature (LT) sintering process for the preparation of high-performance undoped (K,Na)NbO(3) …
Assistive AI in Lung Cancer Screening: A Retrospective Multinational Study in the United States and Japan.
Kiraly AP, Cunningham CA, Najafi R, Nabulsi Z, Yang J, Lau C, Ledsam JR, Ye W, Ardila D, McKinney SM, Pilgrim R, Liu Y, Saito H, Shimamura Y, Etemadi M, Melnick D, Jansen S, Corrado GS, Peng L, Tse D, Shetty S, Prabhakara S, Naidich DP, Beladia N, Eswaran K. Kiraly AP, et al. Among authors: shimamura y. Radiol Artif Intell. 2024 May;6(3):e230079. doi: 10.1148/ryai.230079. Radiol Artif Intell. 2024. PMID: 38477661 Free PMC article.
Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Natsuaki M, Watanabe H, Yamaji K, Ohya M, Nakamura S, Mitomo S, Suwa S, Domei T, Tatsushima S, Ono K, Sakamoto H, Shimamura K, Shigetoshi M, Taniguchi R, Nishimoto Y, Okayama H, Matsuda K, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Suematsu N, Ajimi T, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI Investigators*. Yamamoto K, et al. Among authors: shimamura k. Circ Cardiovasc Interv. 2023 May;16(5):e012922. doi: 10.1161/CIRCINTERVENTIONS.123.012922. Epub 2023 May 16. Circ Cardiovasc Interv. 2023. PMID: 37192307
Long-term outcomes of transapical-transcatheter aortic valve replacement.
Maeda K, Shimamura K, Mizote I, Nakamura D, Yamashita K, Kawamura A, Yoshioka D, Sakata Y, Miyagawa S. Maeda K, et al. Among authors: shimamura k. Gen Thorac Cardiovasc Surg. 2024 Oct 23. doi: 10.1007/s11748-024-02095-x. Online ahead of print. Gen Thorac Cardiovasc Surg. 2024. PMID: 39441472
S1PR3-G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation.
Toyomoto M, Inoue A, Iida K, Denawa M, Kii I, Ngako Kadji FM, Kishi T, Im D, Shimamura T, Onogi H, Yoshida S, Iwata S, Aoki J, Hosoya T, Hagiwara M. Toyomoto M, et al. Among authors: shimamura t. Cell Chem Biol. 2021 Aug 19;28(8):1132-1144.e9. doi: 10.1016/j.chembiol.2021.01.004. Epub 2021 Feb 8. Cell Chem Biol. 2021. PMID: 33561428 Free article.
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report.
Xu S, Shukuya T, Shimamura S, Hayashi T, Sato Y, Shiozaki H, Nishioki T, Nishino K, Kato M, Hattori A, Shimada N, Suzuki K, Kitano S, Takahashi K. Xu S, et al. Among authors: shimamura s. Transl Lung Cancer Res. 2024 Mar 29;13(3):666-672. doi: 10.21037/tlcr-23-765. Epub 2024 Mar 27. Transl Lung Cancer Res. 2024. PMID: 38601437 Free PMC article.
139 results